Featured Research

from universities, journals, and other organizations

FDA Approves New Robotic Surgery Device

Date:
July 17, 2000
Source:
Food And Drug Administration
Summary:
The U.S. Food and Drug Administration has cleared for marketing a robotic device that enables a surgeon to perform laparoscopic gall bladder and reflux disease surgery while seated at a console with a computer and video monitor.

The U.S. Food and Drug Administration has cleared for marketing a robotic device that enables a surgeon to perform laparoscopic gall bladder and reflux disease surgery while seated at a console with a computer and video monitor.

The surgeon uses hand grips and foot pedals on the console to control three robotic arms that perform the surgery using a variety of surgical tools.

The product, the Da Vinci Surgical System, made by Intuitive Surgical, Inc., of Mountain View, Calif., is the first of its kind.

"This system is the first step in the development of new robotic technology that eventually could change the practice of surgery," said FDA Commissioner Jane E. Henney, M.D.

The robotic arms, which have a "wrist" built in to the end of the tool, give surgeons additional manipulation ability during laparoscopic surgery, enabling easier, more intricate motion and better control of surgical tools.

In standard laparoscopic surgery, surgeons pass a laparoscope, a flexible fiberoptic instrument equipped with biopsy forceps, scissors and other surgical tools, through a small incision in the abdominal wall to view the abdominal cavity and perform minor surgery.

The new robotic system is intended to be used in an operating room in laparoscopic procedures, for example for gall bladder disease or gastro-ensophageal reflux disease (severe heartburn).

FDA clearance was based on a review of clinical studies of safety and effectiveness submitted by the manufacturer and on the recommendation of the General and Plastic Surgical Devices Panel of FDA's Medical Devices Advisory Committee.

Intuitive Surgical studied use of the robotic system on 113 patients who underwent surgery for gall bladder or reflux disease, then compared them to 132 patients who received standard laparoscopic surgery.

Results showed that the robotic system was comparable to standard laparoscopic surgery in safety and effectiveness. While the surgical procedures with the robotic device took 40 to 50 minutes longer than standard laparoscopic surgery, this was attributed, in part, to lack of surgical experience with the new technology.

Because of the expected learning curve with the new system, Intuitive Surgical is developing a training program for surgeons in collaboration with FDA.


Story Source:

The above story is based on materials provided by Food And Drug Administration. Note: Materials may be edited for content and length.


Cite This Page:

Food And Drug Administration. "FDA Approves New Robotic Surgery Device." ScienceDaily. ScienceDaily, 17 July 2000. <www.sciencedaily.com/releases/2000/07/000717072719.htm>.
Food And Drug Administration. (2000, July 17). FDA Approves New Robotic Surgery Device. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2000/07/000717072719.htm
Food And Drug Administration. "FDA Approves New Robotic Surgery Device." ScienceDaily. www.sciencedaily.com/releases/2000/07/000717072719.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins